MannKinds inhaled insulin programme, which progressed successfully through phase III clinical testing and gained FDA approval as Afrezza, represents another example of advanced control of particle size, density and dispersibility to enable reliable pulmonary delivery of therapeutics
On a global scale, the widespread uptake of such medications could have the potential to change the economics of food production as we know it
She added that 3 million more consumers have embraced GLP-1 medication in 2025, and that number also is likely to increase in the future as the drug becomes more affordable and available
In some cases, your healthcare provider might consider alternative weight loss strategies, such as adjusting the GLP-1 medication dosage, prescribing a different drug within the same class, or exploring other weight loss options altogether, like bariatric surgery
Kim KY, Kim DS, Lee SK, Lee IK, Kang JH, Chang YS, Jacobs DR, Steffes M, Lee DH